Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A law says any biological materials remaining after diagnostic procedures may be used for research—usually without an individual’s consent.
Collins has led the NIH under three presidents over more than 12 years.
The NIH awarded nearly $470 million to build a national study population of diverse research volunteers.
ER care for uterine fibroids is costly, so women might better manage their issues with regular visits to a trusted health provider.
Researchers attribute disparities in mortality rates to COVID-19–related deaths and persistent health inequities.
Tuskegee Institute researchers are finally being recognized for their work in the development of the polio vaccine.
A new paper in Cell urges medical researchers to actively include more Black and brown people when testing new medical treatments.
The therapy was associated with a reduction in excessive menstrual blood loss, a hallmark of uterine fibroids.
The Senate-passed bill memorializing Henrietta Lacks aims to address underrepresentation in cancer clinical trials.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
Infectious disease researchers worry about their ability to continue working as supplies of N95 respirators dwindle.
Can data from more than 1 million Americans accelerate research and medical breakthroughs that benefit everyone?
A doctor and breast cancer survivor works with the All of Us Research Program, which aims to customize medical treatment for individuals.
Why does the world’s most common liver virus affect humans more than our most recent genetic ancestors?
He also told pharma leaders: “We have to get prices down. We have no choice.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.